217 related articles for article (PubMed ID: 17207628)
1. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness.
Wildeboer D; Naus S; Amy Sang QX; Bartsch JW; Pagenstecher A
J Neuropathol Exp Neurol; 2006 May; 65(5):516-27. PubMed ID: 16772875
[TBL] [Abstract][Full Text] [Related]
3. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-like factor expression in the idiopathic inflammatory myopathies.
Chowdhury MH; Nagai A; Terashima M; Sheikh A; Murakawa Y; Kobayashi S; Yamaguchi S
Acta Neurol Scand; 2008 Aug; 118(2):106-14. PubMed ID: 18294340
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
6. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
7. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.
Figarella-Branger D; Civatte M; Bartoli C; Pellissier JF
Muscle Nerve; 2003 Dec; 28(6):659-82. PubMed ID: 14639580
[TBL] [Abstract][Full Text] [Related]
8. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
Raju R; Dalakas MC
Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
[TBL] [Abstract][Full Text] [Related]
10. Specific matrix metalloproteinase expression in focal myositis: an immunopathological study.
Rodolico C; Mazzeo A; Toscano A; Messina S; Aguennouz M; Gaeta M; Messina C; Vita G
Acta Neurol Scand; 2005 Sep; 112(3):173-7. PubMed ID: 16097959
[TBL] [Abstract][Full Text] [Related]
11. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.
Wiendl H; Mitsdoerffer M; Schneider D; Chen L; Lochmüller H; Melms A; Weller M
FASEB J; 2003 Oct; 17(13):1892-4. PubMed ID: 12923066
[TBL] [Abstract][Full Text] [Related]
12. Cellular mechanisms in inflammatory myopathies.
Hohlfeld R; Goebels N; Engel AG
Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
[TBL] [Abstract][Full Text] [Related]
13. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
De Paepe B; Creus KK; De Bleecker JL
Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
[TBL] [Abstract][Full Text] [Related]
14. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
15. Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
Waschbisch A; Wintterle S; Lochmüller H; Walter MC; Wischhusen J; Kieseier BC; Wiendl H
Arthritis Rheum; 2008 Nov; 58(11):3600-8. PubMed ID: 18975328
[TBL] [Abstract][Full Text] [Related]
16. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies.
Illa I; Gallardo E; Gimeno R; Serrano C; Ferrer I; Juárez C
Am J Pathol; 1997 Jul; 151(1):81-8. PubMed ID: 9212734
[TBL] [Abstract][Full Text] [Related]
17. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies.
Lindberg C; Oldfors A; Tarkowski A
Eur J Immunol; 1994 Nov; 24(11):2659-63. PubMed ID: 7957558
[TBL] [Abstract][Full Text] [Related]
18. The role of ADAM-mediated shedding in vascular biology.
Dreymueller D; Pruessmeyer J; Groth E; Ludwig A
Eur J Cell Biol; 2012; 91(6-7):472-85. PubMed ID: 22138087
[TBL] [Abstract][Full Text] [Related]
19. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
[TBL] [Abstract][Full Text] [Related]
20. Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies.
Schleinitz N; Cognet C; Guia S; Laugier-Anfossi F; Baratin M; Pouget J; Pelissier JF; Harle JR; Vivier E; Figarella-Branger D
Arthritis Rheum; 2008 Oct; 58(10):3216-23. PubMed ID: 18821690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]